ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Blocking glutathione regeneration: Inorganic NADPH oxidase nanozyme catalyst potentiates tumoral ferroptosis

Wu, Chenyao; Xu, Deliang; Ge, Min; Luo, Juanjuan; Chen, Lisong; Chen, Zhixin; You, Yanling; Zhu, Ya-xuan; Lin, Han*; Shi, Jianlin*同济大学; 中国医学科学院
Nano Today2022-10DOI: 10.1016/j.nantod.2022.101574
28被引18阅读
引用收藏
分享

摘要

Emerging cancer cell ferroptosis features the direct depletion of glutathione (GSH) and resultant chemical inhibition on glutathione peroxidase 4 (GPX4) bioactivity, which, unfortunately, is counteracted considerably by nicotinamide adenine dinucleotide phosphate (NADPH)-enabled regeneration of antioxidant GSH. Herein, a Pt-MIL-101 (Fe)-based nanocatalytic medicine (NCM) is proposed to catalyze NADPH oxidation and the following nanozyme catalytic cascade reactions to produce hydroxyl radicals and prevent GSH regeneration, thus promoting the ferroptotic death of cancer cells. Briefly, the Pt-MIL-101 nanomedicine possessing NADPH oxidase (NOX)-like activity catalyzes the superoxide anions (O-2(center dot-)) generation by promoting the electron transfer from NADPH to O-2, followed by Pt-MIL-101-catalyzed O(2)(center dot- )disproportionation producing H2O2 using its superoxide dismutase (SOD) nanozyme catalytic activity. The generated H2O2 further serves as substrate for toxic center dot OH production via Fenton reaction with Fe3+/Fe2+ at the structure center of the MIL-101. Moreover, the NOX nanozyme-catalyzed NADPH depletion by the nanomedicine largely prevents the GSH regeneration and de-activates GPX4, promoting lipid peroxidation for ferroptotic cell death. This work highlights an effective NADPH-initiated nanozyme cascade nanocatalytic strategy for ferroptosis-based tumor therapy.

学科与关键词

关键词
Nanocatalytic medicineNanozyme catalystCascade catalysisNADPH oxidaseFerroptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Nano Today
发表日期
2022-10
卷期
第 46 卷
页码
101574
DOI
10.1016/j.nantod.2022.101574
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [52002391, 21835007]; Key Research Program of Frontier Sciences, Chinese Academy of Sciences [ZDBS-LY-SLH029]; Basic Research Program of Shanghai Municipal Government [21JC1406000]; CAMS Innovation Fund for Medical Sciences [2021-I2M-5-012]

作者

  • W

    Wu, Chenyao (第一作者)

  • X

    Xu, Deliang

    chinese acad med sci · shanghai inst ceram

查看全部 10 位作者收起作者
  • G

    Ge, Min

    chinese acad med sci · shanghai inst ceram

  • L

    Luo, Juanjuan

  • C

    Chen, Lisong

  • C

    Chen, Zhixin

    chinese acad med sci · shanghai inst ceram

  • Y

    You, Yanling

    chinese acad med sci · shanghai inst ceram

  • Z

    Zhu, Ya-xuan

    chinese acad med sci · shanghai inst ceram

  • L

    Lin, Han (通讯)

    tongji univ · chinese acad med sci · shanghai inst ceram

  • S

    Shi, Jianlin (通讯)

    chinese acad med sci · tongji univ · shanghai inst ceram

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417